Target Name: ZNF500
NCBI ID: G26048
Review Report on ZNF500 Target / Biomarker Content of Review Report on ZNF500 Target / Biomarker
ZNF500
Other Name(s): ZNF500 variant 1 | Zinc finger protein with KRAB and SCAN domains 18 | Zinc finger protein 500 (isoform 1) | ZKSCAN18 | zinc finger protein 500 | ZSCAN50 | Zinc finger protein 500 | Zinc finger protein 500, transcript variant 1 | KIAA0557 | ZN500_HUMAN | zinc finger protein with KRAB and SCAN domains 18

ZNF500: A Non-Code RNA Molecule as A Potential Drug Target and Biomarker for Various Diseases

ZNF500 (Zinc Finger Nucleotide Repeat 500) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZNF500 is a member of the ZNF family of proteins, which are known for their role in regulating gene expression and DNA replication.

The ZNF500 molecule is made up of 1,924 nucleotides and has a unique structure that consists of a core repeat unit and a variable region. The core repeat unit is a 15-mer repeat sequence, which is composed of 11 distinct nucleotides. The variable region includes a variable number of exons that can result in a highly variable protein product.

ZNF500 has been shown to play a role in a variety of cellular processes, including cell growth, differentiation, and DNA replication. For example, studies have shown that overexpression of ZNF500 can promote the growth and survival of cancer cells, while inhibition of ZNF500 has been shown to inhibit the growth and survival of cancer cells.

In addition to its role in cancer, ZNF500 has also been shown to be involved in a variety of other cellular processes, including cell signaling, cell adhesion, and neurodegenerative diseases. For example, studies have shown that overexpression of ZNF500 can promote the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, while inhibition of ZNF500 has been shown to protect against neurodegenerative diseases.

The potential drug target for ZNF500 is its role in promoting the growth and survival of cancer cells, as well as its involvement in neurodegenerative diseases. Therefore, ZNF500 has been targeted by a variety of therapeutic strategies, including inhibition of its expression, gene editing, and RNA interference.

In addition to its potential as a drug target, ZNF500 has also been identified as a potential biomarker for a variety of diseases. For example, studies have shown that ZNF500 levels are elevated in a variety of cancer types, including breast, lung, and ovarian cancer. Additionally, ZNF500 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and has been shown to be associated with the development of certain neurodegenerative diseases.

Overall, ZNF500 is a promising drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in these diseases and to develop effective therapies.

Protein Name: Zinc Finger Protein 500

Functions: May be involved in transcriptional regulation

The "ZNF500 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF500 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605